PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15084589-11	2004	Cell preincubation with Go6983 strongly diminished H(2)O(2)-induced nuclear relocalization of GFP-PKD.	2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide	24-30	protein kinase D1	Mus musculus	98-101	
19289471-4	2009	Cell treatment with the preferential PKC inhibitors GF109203X or Go6983 profoundly inhibited PKD activation induced by bombesin stimulation for <15 min but did not prevent PKD catalytic activation induced by bombesin stimulation for longer times (>60 min).	2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide	65-71	protein kinase D1	Mus musculus	93-96	
21345437-5	2011	PKD activators decreased expression of the adiponectin gene, and its inhibition by PKD siRNA and by a selective inhibitor Go6983 canceled this effect.	2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide	122-128	protein kinase D1	Mus musculus	0-3	
12065737-9	2002	Conversely, Go6983 [2-[1-(3-dimethylaminopropy)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl)maleimide], a similar compound that also selectively inhibits conventional PKCalpha, but not PKD, had little or no effect on DNA synthesis or transglutaminase activity (up to 1 microM).	2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide	12-18	protein kinase D1	Mus musculus	179-182